Provecs Medical is a biopharmaceutical company developing immune gene therapy for cancer. It provides exviro, a proof-of-concept platform for ex-vivo therapy simulation in primary human cancer tissues. It allows monitoring of immune processes by big data transcriptome profiling, bioinformatics, and tissue immune imaging technologies.